Marci Lerner

Part of Hologic, Inc., Hologic UK Finance Ltd. provides business support services. The company is based in Manchester, UK and was founded in 2015.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Faxitron Bioptics LLC manufactures x-ray equipment for specimen radiography, research, and NDT applications in medical facilities, and scientific and industrial laboratories. The firm products include TruNode, BioVision, Wedge, PathVision, and CoreVision. The company was founded in July 2011 and is headquartered in Tucson, AZ.

Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.

Faxitron Bioptics LLC manufactures x-ray equipment for specimen radiography, research, and NDT applications in medical facilities, and scientific and industrial laboratories. The firm products include TruNode, BioVision, Wedge, PathVision, and CoreVision. The company was founded in July 2011 and is headquartered in Tucson, AZ.

Health Beacons, Inc. provides radio frequency technology services to improve healthconditions. Its products include virtual hookwire RFID tags, sterilized syringe delivery system, and tagfinder and reader. The company was founded by Murray Reicher and Robert Petcavich and is headquartered in Kirkland, WA.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Health Beacons, Inc. provides radio frequency technology services to improve healthconditions. Its products include virtual hookwire RFID tags, sterilized syringe delivery system, and tagfinder and reader. The company was founded by Murray Reicher and Robert Petcavich and is headquartered in Kirkland, WA.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Part of Hologic, Inc., Hologic UK Finance Ltd. provides business support services. The company is based in Manchester, UK and was founded in 2015.

Part of Hologic, Inc., Hologic UK Finance Ltd. provides business support services. The company is based in Manchester, UK and was founded in 2015.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.

Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.

Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.

Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.